This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre Hospitalier Universitaire De Toulouse, National Institute of Health and Medical Research, Université Paul Sabatier (Toulouse III). Active years: 2021.
Company Filing History:
1 out of 29 
1 out of 1,853 
1 out of 161 
Years Active: 2021
Title: Anne Montfort: Innovator in Cancer Immunotherapy
Introduction
Anne Montfort is a prominent inventor based in Toulouse, France. She has made significant contributions to the field of cancer immunotherapy, particularly through her innovative methods and pharmaceutical compositions aimed at enhancing immune responses in cancer patients. Her work is crucial in the ongoing battle against cancer, providing new avenues for treatment.
Latest Patents
Anne Montfort holds a patent for "Methods and pharmaceutical compositions for enhancing CD8+ T cell-dependent immune responses in subjects suffering from cancer." This invention focuses on a method to enhance the CD8+ T cell-dependent immune response by administering a therapeutically effective amount of an agent capable of increasing intra-tumoral ceramide content. This groundbreaking approach has the potential to improve treatment outcomes for cancer patients.
Career Highlights
Throughout her career, Anne has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Paul Sabatier Toulouse III. Her dedication to research and innovation has positioned her as a key figure in the field of cancer research.
Collaborations
Anne Montfort has collaborated with notable professionals in her field, including Thierry Levade and Bruno Segui. These partnerships have further enriched her research and contributed to the advancement of cancer therapies.
Conclusion
Anne Montfort's work exemplifies the vital role of innovation in the fight against cancer. Her contributions through her patent and collaborations highlight her commitment to improving patient outcomes and advancing medical science.